Category NEWS

Argonne Studies Pollutant-Destroying Molecules for Water Treatment

Researchers at Argonne National Laboratory analyze reactive molecules generated during electrocatalysis to better understand how electricity-driven processes can break down persistent water pollutants Modern society relies on thousands of synthetic chemicals that improve everyday life, from vibrant textile dyes to…

Read MoreArgonne Studies Pollutant-Destroying Molecules for Water Treatment

Enterprise Products Partners Publishes 2025 Investor Letter

Enterprise Products Partners Shares 2025 Investor Letter Highlighting Strategic Growth, Market Outlook, and Operational Performance. Enterprise Products Partners L.P. has released its 2025 Letter to Investors, providing stakeholders with insights into the partnership’s operational performance, strategic priorities, and long-term outlook.…

Read MoreEnterprise Products Partners Publishes 2025 Investor Letter

LabVantage lanza CORTEX: LIMS potenciado por IA para laboratorios

LabVantage Solutions has introduced a new artificial intelligence–driven platform designed to transform how laboratories manage data, workflows, and automation. The company announced the launch of LabVantage CORTEX, a next-generation platform that combines artificial intelligence (AI), advanced analytics, and automation technologies…

Read MoreLabVantage lanza CORTEX: LIMS potenciado por IA para laboratorios

Genentech Reports Positive Phase II Results for Petrelintide in Overweight and Obesity

Genentech Reports Positive Phase II Results for Petrelintide, an Amylin Analog for Overweight and Obesity Genentech, a member of the Roche Group today announced positive topline results from the Phase II ZUPREME-1 trial evaluating the investigational drug petrelintide versus placebo…

Read MoreGenentech Reports Positive Phase II Results for Petrelintide in Overweight and Obesity

NEJM Publishes First Evidence of Disease Modification in Dravet Syndrome

New Study in NEJM Highlights Potential Disease-Modifying Treatment for Dravet Syndrome Biotechnology company Stoke Therapeutics and global neuroscience firm Biogen have announced the publication of important new research on the investigational medicine zorevunersen in the prestigious medical journal The New…

Read MoreNEJM Publishes First Evidence of Disease Modification in Dravet Syndrome